AXSM vs SCHW · rev $409.6M vs P/E 19, rev $13.55B
Axsome Therapeutics Inc (AXSM) versus Charles Schwab Corp (SCHW) — a side-by-side from cached financials, not a winner call.
Axsome Therapeutics Inc (AXSM) is a biotechnology company listed on US.
Charles Schwab Corp (SCHW) is a capital markets company listed on NYSE. It is led by Richard Andrew Wurster C.F.A., CMT.
Latest reported AXSM revenue for 2026-06-30 was $409.6M. Net income was -$115.9M. AXSM currently screens at market cap $11.96B.
Latest reported SCHW revenue for 2026-06-30 was $13.55B. Net income was $5.28B. SCHW currently screens at market cap $164.37B and trailing P/E 18.8.
AXSM currently screens at market cap $11.96B. SCHW currently screens at market cap $164.37B and trailing P/E 18.8.
Not investment advice. Open the AXSM and SCHW stock pages for the full models.
Not investment advice.